Sangamo Therapeutics
SGMO
SGMO
197 hedge funds and large institutions have $729M invested in Sangamo Therapeutics in 2018 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 52 increasing their positions, 77 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
34% less capital invested
Capital invested by funds: $1.1B → $729M (-$368M)
43% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 42
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
197
Holding in Top 10
1
Calls
$21.9M
Puts
$20.5M
Top Buyers
| 1 | +$15.5M | |
| 2 | +$11.7M | |
| 3 | +$10.1M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
+$9.67M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$8.03M |
Top Sellers
| 1 | -$10.6M | |
| 2 | -$8.36M | |
| 3 | -$7.88M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$6.92M |
| 5 |
TAM
Tocqueville Asset Management
New York
|
-$6.8M |